Speakers

 

 

Key Speakers

Lord James (Jim) O’Neil, Honorary Professor of Economics at the University of Manchester & author of AMR review UK Lord James (Jim) O’Neil
Honorary Professor of Economics
University of Manchester & Author of AMR Review UK

Ana Maria Henao-Restrepo MD, Team Leader, Implementation Research Initiative for Vaccine Research, WHO Ana Maria Henao-Restrepo MD
Team Leader, Implementation Research Initiative for Vaccine Research
WHO

Emily Erbelding, M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH Dr Merlin Robb
Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP
U.S. Military HIV Research Program

Dr Melanie Saville, Director of Vaccine Development, CEPI Dr Melanie Saville
Director of Vaccine Development
CEPI

Dr Thomas G. Evans, CEO, Vaccitech Dr Thomas G. Evans
CEO
Vaccitech

Dr Laszlo Radvanyi, Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology, EMD Serono Dr Laszlo Radvanyi
Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology
EMD Serono

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Ruxandra Draghia-Akli, Vice President of Vaccines Public Health & Scientific Affairs, Merck (MSD) Sarah Gilbert
Professor of Vaccinology 
University of Oxford

Dr Wayne Koff, President & CEO, The Human Vaccines Project Dr Wayne Koff
President & CEO
The Human Vaccines Project

Professor Helen McShane, Professor of Vaccinology, Jenner Institute, Oxford University Professor Helen McShane
Professor of Vaccinology, Jenner Institute
Oxford University

Agenus Inc Dr Alex Duncan
Chief Technology Officer and Head of Research
Agenus Inc

 

 

 

2018 SPEAKERS FOR
 

Dr Dicky Abraham, Executive Director/Distinguished Scientist, Merck, United States

Prof Jeffrey Almond, Former Vice President Discovery Research and Development, Sanofi and Visiting Professor, University of Oxford - Oxford Vaccine Group, United Kingdom

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer, United States

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial, France

Dr Jean-Christophe Audonnet at World Vaccine Congress Europe

Dr Joeri Auwerx, Director, Discovery Research, ViroVet N.V., Belgium

Dr Lorne Babiuk, Former Vice President Research, University of Alberta, Canada

Dr Frank Baehner, Area Head Prophylactic Vaccines, CureVac, Germany

Dr Carl Barrett, Vice President of Translational Sciences, AstraZeneca Pharmaceuticals, United States

Dr Philip Beer, Physician Scientist and Precision Oncology Specialist, Sanger Institute, United Kingdom

Professor Fernando M. A. Bernardo, Chief of Veterinary Office, Portugal, DGAV, The Portuguese National Authority for Animal Health, Portugal

Dr Todd Black, Executive Director, Infectious Diseases, MSD, United States

Prof Marc Bonten, Professor, UMC Utrecht, Netherlands

Prof Marc Bonten at World Vaccine Congress Europe

Dr Maximilian Bosch, Medical Scientific Director, Pantec Biosolutions, Liechtenstein

Prof Anne Botteaux, Molecular Bacteriology Laboratory, Universite Libre De Bruxelles, Belgium

Prof Anne Botteaux at World Vaccine Congress Europe

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK, France

Dr Helen Bright, Director, Flu Biopharm Development, MedImmune, United Kingdom

Dr Kate Broderick, Vice President, Research and Development, Inovio Pharmaceuticals, United States

Adam Buckley, VP Business Development, VBI Vaccines, United States

Dr Rosario Bullido, Head of Vet Inmuno Medicines Assessment Unit, Aemps, Spain

Dr Rosario Bullido at World Vaccine Congress Europe

Dr Miles Carroll, Deputy Director, Public Health England, United Kingdom

Dr Senyon Choe, President of Mogam Institute for Biomedical Research & Professor, U.C.S.D., United States

Ashok Chopra, Distingushed Professor, University of Texas Medical Branch, United States

Prof Dennis Christensen, Head of Vaccine Adjuvant Research grp., Dept. Infectious Disease Immunology, Statens Serum Institute - Denmark, Denmark

Dr Chris Clarke, Global Medical Affairs Director, GSK Vaccines, Belgium

Dr Ralf Clemens, SVP, Grid Rio, Germany

Dr Ralf Clemens at World Vaccine Congress Europe

Dr Jeffrey Cohen, Chief of Laboratory of Infectious Diseases, NIH, United States

Professor Louise Cosby, Head of Virology, Agri-Food and Biosciences Institute, United Kingdom

Marc Andre D Aoust, Vice President of Research and Innovation, Medicago, Canada

Marc Andre D Aoust at World Vaccine Congress Europe

Prof Ron Dagan, head, pediatric Infectious diseases, Ben Gurion University, Israel

Morena D'Alise, Lead Immunologist, Nouscom, Italy

Michel De Baar, Executive Director BD & Licensing Europe, MSD, United Kingdom

Dr Isabel de la Mata, Principal Advisor for Health and Crisis management, European Commission, Belgium

Dr Evelyna Derhovanessian, Senior Scientist, BioNTech Ag, Germany

Dr Dimitri Diavatopoulos, Department of Pediatrics/ Laboratory of Pediatric Infectious Diseases (LPID), Radboud Center for Infectious Diseases, Netherlands

Dr Dimitri Diavatopoulos at World Vaccine Congress Europe

Dr Thomas G. Evans, Vaccitech, United Kingdom

Dr Ali Fattom, Sr. VP of Vaccines Research and Development, BlueWillow Biologics, United States

Dr Martin Friede, Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department, WHO, Switzerland

Roman Galetto, Group Lead, Preclinical Manager, Cellectis Therapeutics, France

Kirsty Gapp, Global Business Manager Transdermal and Microneedle Drug Delivery, 3M, United Kingdom

Kirsty Gapp at World Vaccine Congress Europe

Christiane Gerke, Head of Vaccine Programs, Institut Pasteur, France

Christiane Gerke at World Vaccine Congress Europe

Dr Arin Ghasparian, CEO, Virometix AG, Switzerland

Sarah Gilbert, Professor of Vaccinology, University of Oxford, United Kingdom

Dr David Gilham, Vice President of Research and Development, Celyad, Belgium

Dr Gregory Glenn, President, Research and Development, Novavax, United States

Cori Gorman, Vice President Of Precision Medicine & Manufacturing, Agenus, unknown

Dr Farshad Guirakhoo, CSO, GeoVax, Inc., United States

Professor Carlos A. Guzman, Head of the Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Germany

Dr Bassam Hallis, Head of Pre Clinical Development and General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis at World Vaccine Congress Europe

Prof Mark Hatherill, Professor, S.A. Tuberculosis Vaccine Initiative, South Africa

Prof Mark Hatherill at World Vaccine Congress Europe

Professor John Hayball, Professor, University of South Australia, Australia

Professor Peter Heegaard, Professor, National Veterinary Institute Technical University of Denmark, Denmark

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organisation, Switzerland

Dr Hanjo Hennemann, Chief Scientific Officer and Co Founder, VEROVACCiNES, Germany

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited, United Kingdom

Dr Tim Hirst, CEO, GPN Vaccines, Australia

Dr Karin Hoelzer, Senior Officer, The Pew Charitable Trusts, United States

Dr Mark Howarth, Professor, University of Oxford, United Kingdom

Professor Dirk Jager, Managing Director, University Hospital of Heidelberg, Germany

Professor Dirk Jager at World Vaccine Congress Europe

Konrad Janik, Acting Medical Manager, Institute of Sera Biotechnology & Vaccines BIOMED, Poland

Dr Jan Jezek, Chief Scientific Officer, Arecor Ltd, United Kingdom

Professor Gregers Jungersen, Professor of Veterinary Immunology and Vaccinology, Technical University of Denmark, Denmark

Professor Lana Kandalaft, Director, Center of Experimental Therapeutics, University of Lausanne, Switzerland

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals, United States

Paula Kinnunen, Research Director, Food Safety Authority Evira, Finland

Dr Olivier Kitten, Chief Executive Officer, Affilogic, France

Dr Elizabeth Klemm, Project Officer, Wellcome Trust, United Kingdom

Dr Wayne Koff, President and CEO, The Human Vaccines Project, United States

Dr Alexander Kort, SVP Corporate Development, Themis Bioscience GmbH, Austria

Professor Jeroen Kortekaas, Wageningen University, Netherlands

Carlos Pinero Lambea, Researcher, Centre for Genomic Regulation, Spain

Nathalie Landry, Executive Vice President, Scientific & Medical Affairs, Medicago, Canada

Dr Yotam Levin, Chief Executive Officer, NanoPass Technologies, Israel

Maria Lluch Senar, Co-Cordinator, Centre for Genomic Regulation, Spain

Dr Stephen Lockhart, Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD), Pfizer, United Kingdom

Dr Patricia Londono-Hayes, Sr. Director / Head R&D Initiatives, Europe, Sanofi, France

Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences, Netherlands

Dr Anthony Simon Lynch, Senior Scientific Director, Janssen R&D, Netherlands

Pedro Madureira, CSO, Immunethep, Portugal

Dr Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership, Netherlands

Dr Anna-Karin Maltais, Chief Scientific Officer, Eurocine Vaccines AB, Sweden

Dr Michael Manns, Professor, Hannover Medical School, Germany

Dr Michael Manns at World Vaccine Congress Europe

Dr Victor Mbao, Senior Program Specialist, International Development Research Centre, Kenya

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc., United States

Professor Helen Mcshane, Professor Of Vaccinology Wellcome Senior Fellow PI Head Of TB Vaccines Group, The Jenner Institute - University of Oxford, United Kingdom

Dr Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals, Netherlands

Dr Maria Mellado, Application Specialist, Puritifcation Technologies, Sartorius Stedim Biotech, United States

Prof Kingston Mills, Professor of Experimental Immunology, Trinity College Dublin, Ireland

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi, Italy

Dr Geert Mudde, Chief Scientific Officer and Founder, OncoQR ML, Austria

Dr Tarit Mukhopadhyay, Senior Lecturer of Vaccine Bioprocess Development, University College London, United Kingdom

Dr Mel Munro, Project Manager, Biologicals Regulatory Affairs, Triveritas Limited, United Kingdom

Dr Mel Munro at World Vaccine Congress Europe

Imraan Munshi, Global Communications Lead, Vaccines, MSD, United States

Andreas Neubert, Vice President Vaccines, IDT Biologika, Germany

Claire Nguyen Le, Exec Director, Clinical Development, Syneos Health, France

Claire Nguyen Le at World Vaccine Congress Europe

Dr Mikkel Nissum, Technical Development Leader, GSK Vaccine, Italy

Lord Jim O'Neill, Honorary Professor of Economics at the University of Manchester & author of AMR review UK, The University of Manchester, United Kingdom

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Netherlands

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Netherlands

Dr Arto Palmu, Research manager, head of Clinical Research Team, Public Health Evaluation and Projection Unit, Department of Public Health Solu, Finnish National Institute for Health and Welfare, Finland

Dr Cristina Peixoto, Head of Downstream Process A.C.T.U., iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Dr Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation, United States

Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen, Netherlands

Andrew Potter, CEO, VIDO-InterVac, Canada

Geert Preuveneers, Head of Regulatory Affairs Europe, MSD, Belgium

Geert Preuveneers at World Vaccine Congress Europe

Prof Roman Prymula, Professor Preventive Medicine, Charles University in Prague, Czech Republic

Prof Roman Prymula at World Vaccine Congress Europe

Dr Ahmadur Rahman, Senior Clinical Director Oncology, MSD, United Kingdom

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines, United States

Prof Robert Read, Head of Academic Unit - Clinical and Experimental Sciences, Professor of Infectious Diseases, Honorary Consultant Physician, University of Southampton, United Kingdom

Dr Merlin Robb, Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP, U.S. Military HIV Research Program, United States

Antonio Roldao, Senior Researcher, iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines, United States

Michael Salter, R&D Facilitator, A.B. Agri, United Kingdom

Dr Adel Samson, Lead, Translational Cancer Immunotherapy Group, University of Leeds, United Kingdom

Dr Adel Samson at World Vaccine Congress Europe

Dr Melanie Saville, Director Vaccine Development, CEPI, France

Dr Hanneke Schuitemaker, Vice President and Head of Viral Vaccine Discovery and Translational Medicine, Janssen, Netherlands

Dr Joerg (Jörg) Schwinde, Eppendorf AG, Germany

Dr Joerg (Jörg) Schwinde at World Vaccine Congress Europe

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences, United States

Dr Ruud Segers, Executive Director, Clinical Research & Head Global Swine Biologicals R&D, MSD Animal Health, Netherlands

Dr Katherine Shives, R&D Scientist, Sartorius-Stedim-Biotech, United States

Ricardo Silva, Researcher, iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Ricardo Silva at World Vaccine Congress Europe

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services, Belgium

Bruno Speder at World Vaccine Congress Europe

Prof Daniel Speiser, Head of Clinical Tumour Biology and Immunotherapy Group, University of Lausanne, Switzerland

Julia Spencer, Executive Director, Global Vaccine Policy & Government Relations, MSD, United States

Dr Koert Stittelaar, Director Preclinical Services, Viroclinics Biosciences, Netherlands

Dr Christine Tait-Burkard, Assistant Professor, The Roslin Institute, United Kingdom

Dr Sybil Tasker, Chief Medical Officer, Altimmune, United States

Dr Mark Throsby, Chief Scientific Officer, Merus B.V., Netherlands

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics, Netherlands

Dr Peter Timmerman at World Vaccine Congress Europe

Dr Lincoln Tubbs, Director, Food Animal Vaccines R&D, Elanco Animal Health, United States

Aernout Van Haarst, Director of Scientific Affairs, Celerion, United Kingdom

Dr Elly Van Riet, Head of Exploratory and Clinical Research, Intravacc, Netherlands

Dr Joris Vandeputte, President, IABS, Belgium

Elisenda Viaplana, Senior Scientist, Zoetis, Spain

Dr Arne Von Bonin, Chief Scientific Officer, Vaxxilon AG, Switzerland

Dr Jun Wang, Genentech/Roche Pharmaceuticals Division, Switzerland

Professor Mark Wilcox, Professor of Medical Microbiology & Deputy-Chair, APRHAI, University of Leeds, United Kingdom

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services, Switzerland

Dr Paul Williams, Technical Manager, MSD Animal Health, United Kingdom

Dr Dong Yu, Director and Function Head, GSK Vaccines, United States

Dr Giovanna Zanoni, Assistant Director, Immunology Unit, University Hospital in Verona Italy, Italy

Fred Zepp, Medical Director and Chairman, University Medicine Mainz, Germany

Fred Zepp at World Vaccine Congress Europe

Dr Mai-Britt Zocca, Chief Executive Officer and Founder, IO Biotech ApS, Denmark

Dr Alfredo Zurlo, Chief Medical Officer, Glycotope, Germany

 

 

Sign Up for Event Updates